BREAKTHROUGH T1D: Form 990, tax year 2016

View the entire original 990 at ProPublica ↗

Organization
BREAKTHROUGH T1D (EIN 23-1907729)
Tax period
2016-07-01 to 2017-06-30
Filed
2017-12-20
IRS object ID
201723549349300112
Schema version
2016v3.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2017-12-20T10:09:44-06:00ReturnTs
Tax Period End2017-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1KPMG LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1345 PARK AVEAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10154ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2016-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN231907729EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1JDRF INTERNATIONALBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% GARY CURTO C/O JDRF INTInCareOfNm
Business Name ControlJDRFBusinessNameControlTxt
Phone2127859500PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line126 BROADWAY 15TH FLAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonMARK GREENEPersonNm
Person TitleCFOPersonTitleTxt
Phone6468734311PhoneNum
Signature2017-12-20SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonDEVIN L DUNCANPreparerPersonNm
PTINP01249521PTIN
Phone2127859700PhoneNum
Preparation2017-12-18PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address167.68.102.5IPv4AddressTxt
FieldValueIRS element (for citing)
Federal Original Submission Id20543020173545000000FederalOriginalSubmissionId
Federal Original Submission Id2017-12-20FederalOriginalSubmissionIdDt
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdE665B3E7A8D0C3A51E67724EBAB5121B0EE8EB14AtSubmissionCreationDeviceId
At Submission Filing Device IdBBEE8D8720ADAD65542A46A6E57F18F679A29BCDAtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2016TaxYr
Build TS2018-03-14 21:41:22ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerDEREK RAPPPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line126 BROADWAY 14TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$230,050,266GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.jdrf.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1970FormationYr
Legal Domicile StatePALegalDomicileStateCd
Activity Or MissionAccelerating life-changing breakthroughs to cure, prevent and treat Type 1 Diabetes and its complications. SEE SCHEDULE OActivityOrMissionDesc
Voting Members Governing Body33VotingMembersGoverningBodyCnt
Voting Members Independent31VotingMembersIndependentCnt
Total Employee886TotalEmployeeCnt
Total Volunteers300000TotalVolunteersCnt
Total Gross UBI$45,150TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$33,150NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$196,804,267PYContributionsGrantsAmt
CY Contributions Grants$199,896,852CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$6,524,427PYInvestmentIncomeAmt
CY Investment Income$1,227,269CYInvestmentIncomeAmt
PY Other Revenue$1,027,088PYOtherRevenueAmt
CY Other Revenue$1,129,676CYOtherRevenueAmt
PY Total Revenue$204,355,782PYTotalRevenueAmt
CY Total Revenue$202,253,797CYTotalRevenueAmt
PY Grants And Similar Paid$75,084,432PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$79,009,656CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$74,149,309PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$75,347,284CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$25,764,003CYTotalFundraisingExpenseAmt
PY Other Expenses$40,245,664PYOtherExpensesAmt
CY Other Expenses$39,432,392CYOtherExpensesAmt
PY Total Expenses$189,479,405PYTotalExpensesAmt
CY Total Expenses$193,789,332CYTotalExpensesAmt
PY Revenues Less Expenses$14,876,377PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$8,464,465CYRevenuesLessExpensesAmt
Total Assets BOY$197,093,128TotalAssetsBOYAmt
Total Assets EOY$198,753,573TotalAssetsEOYAmt
Total Liabilities BOY$133,197,854TotalLiabilitiesBOYAmt
Total Liabilities EOY$121,385,069TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$63,895,274NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$77,368,504NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionJDRFs mission is to accelerate life-changing breakthroughs to cure, prevent and treat Type 1 Diabetes (T1D) and its complications. JDRF is the leading global organization focused on T1D research and is committed to funding the development of new therapies and treatments to keep people with T1D healthier, longer, until a cure is found. Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. JDRF works every day to change the reality of this life-threatening autoimmune disease for millions of people - and to prevent anyone else from contracting the disease - by funding research, advocating for government support of research and new therapies, ensuring new therapies and technologies come to market, and connecting and engaging the T1D community. JDRF has funded more than $2 billion in research to date and made significant progress in understanding and fighting the disease. JDRF has played a role in nearly every T1D therapeutic advance of the pastMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$79,009,656ExpenseAmt
Grant$79,009,656GrantAmt
DescRESEARCH FUNDING FOR THE FY17 PERIOD ENDING JUNE 30, 2017, JDRF DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $79 MILLION IN RESEARCH GRANT NET EXPENSE WAS RECOGNIZED ACCORDING TO GAAP AND EXCLUDING $7.1 MILLION OF PROGRAMMATIC RESEARCH INVESTMENTS WHICH ARE RECORDED TO THE ORGANIZATIONS BALANCE SHEET. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO DIRECT RESEARCH FUNDING. SEE SCHEDULE O.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$20,866,569ExpenseAmt
DescRESEARCH SUPPORT JDRF MAINTAINS AN IN-HOUSE TEAM OF SKILLED SCIENTIFIC, MEDICAL, POLICY AND GOVERNMENT RELATIONS PROFESSIONALS WHO PLAY A CRITICAL ROLE IN LEADING AND SUPPORTING THE EVALUATION OF RESEARCH FUNDING OPPORTUNITIES BY JDRF AND INFLUENCING RESEARCH DIRECTION AND THE DISBURSEMENT OF RESEARCH FUNDS FROM OTHERS. THESE PROFESSIONALS ALSO WORK WITH REGULATORY AND POLICY OFFICIALS TO ENSURE THAT RESEARCH CAN PROCEED WITHOUT DELAY AND RESULTS ARE UNDERSTOOD BY HEALTHCARE DECISION MAKERS. SEE SCHEDULE O.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$52,763,561ExpenseAmt
DescPUBLIC EDUCATION AND OUTREACH JDRF EDUCATES THE COMMUNITY AND PROVIDES OUTREACH SERVICES TO NEWLY DIAGNOSED CHILDREN AND ADULTS, THEIR FAMILIES AND OTHERS ABOUT T1D AND ITS COMPLICATIONS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO PUBLIC EDUCATION AND OUTREACH. SEE SCHEDULE O.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$152,639,786TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredfalseScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (true)ReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesYes (true)GamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemYes (true)BusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityYes (true)DisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntfalseTransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
Info In Schedule O Part VYes (X)InfoInScheduleOPartVInd
IRP Document964IRPDocumentCnt
IRP Document W2 G6IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee886EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountYes (true)ForeignFinancialAccountInd
Foreign CountryISForeignCountryCd
Foreign CountryDAForeignCountryCd
Foreign CountryNLForeignCountryCd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Form1098 C FiledYes (true)Form1098CFiledInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members33GoverningBodyVotingMembersCnt
Independent Voting Member31IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersYes (true)LocalChaptersInd
Policies Reference ChaptersYes (true)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VentureYes (true)InvestmentInJointVentureInd
Written Policy Or ProcedureYes (true)WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldIDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldIAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldLAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTXStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWYStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonGARY CURTO CO JDRF INTPersonNm
Phone2124797551PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line126 BROADWAY 1TH FLAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (43 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
MAARTEN DE GROOT FY15-17
BOARD MEMBER3.00.0Yes (X)$0$0$0
LORNE SHIFF FY15-17
BOARD MEMBER3.00.0Yes (X)$0$0$0
NICOLE JOHNSON FY16-17
BOARD MEMBER3.00.0Yes (X)$0$0$0
MIKE LEE FY16-18
BOARD MEMBER3.00.0Yes (X)$0$0$0
LARRY SOLER FY16-18
SECRETARY/CHAIR, NOM & GOV7.00.0Yes (X)$0$0$0Yes (X)
WENDY WOOD FY16-18
BOARD MEMBER5.00.0Yes (X)$0$0$0
NANETTE DETURK FY17-19
BOARD MEMBER3.00.0Yes (X)$0$0$0
MICHELLE GRIFFIN FY17-19
CHAIR, DEVELOPMENT7.00.0Yes (X)$0$0$0
STEPHEN NEWMAN MD FY17-19
CHAIR, RESEARCH7.00.0Yes (X)$0$0$0
LISA ALTMAN FY15-17
BOARD MEMBER3.00.0Yes (X)$0$0$0
GRANT BEARD FY15-17
TREASURER/CHAIR, FINANCE7.00.0Yes (X)$0$0$0Yes (X)
RANDY ANDERSON FY15-17
BOARD MEMBER3.00.0Yes (X)$0$0$0
TIMOTHY CLARK FY15-17
CHAIR, INVESTMENT7.00.0Yes (X)$0$0$0
MARK FISCHER-COLBRIE FY16-18
CHAIRMAN OF THE BOARD20.00.0Yes (X)$0$0$0Yes (X)
SCOTT MCCORMICK FY15-17
BOARD MEMBER3.00.0Yes (X)$0$0$0
LISA REED FY15-17
BOARD MEMBER3.00.0Yes (X)$0$0$0
RED MAXWELL FY15-17
BOARD MEMBER3.00.0Yes (X)$0$0$0
MARVIN DAITCH FY16-18
BOARD MEMBER3.00.0Yes (X)$0$0$0
PAM EDMONDS FY16-18
CHAIR, ADVOCACY7.00.0Yes (X)$0$0$0
PAT MCFEELEY FY16-17
CHAIR, CHANCELLORS7.00.0Yes (X)$0$0$0
JEFF PLUMER FY16-18
CHAIR, AUDIT7.00.0Yes (X)$0$0$0
LORRAINE STIEHL FY15-17
BOARD MEMBER3.00.0Yes (X)$0$0$0
LISA WALLACK FY16-18
BOARD MEMBER3.00.0Yes (X)$0$0$0
SEAN DOHERTY FY17-19
CHAIR, JDRF T1D FUND LLC7.00.0Yes (X)$0$0$0
PAUL HEATH FY17-19
BOARD MEMBER3.00.0Yes (X)$0$0$0
KAREN JORDAN FY17-19
BOARD MEMBER3.00.0Yes (X)$0$0$0
JOHN KAMPFE FY17-19
BOARD MEMBER3.00.0Yes (X)$0$0$0
ELLEN LEAKE FY17-19
BOARD VICE-CHAIR10.00.0Yes (X)$0$0$0Yes (X)
DOUG LOWENSTEIN FY17-19
BOARD MEMBER3.00.0Yes (X)$0$0$0
DAYTON OGDEN FY17-19
CHAIR, TALENT & COMPENSATION7.00.0Yes (X)$0$0$0
ANGIE PLATT FY17-19
BOARD MEMBER3.00.0Yes (X)$0$0$0
JERRY WISLER FY17-19
BOARD MEMBER3.00.0Yes (X)$0$0$0
KAREY L WITTY FY17-19
BOARD MEMBER3.00.0Yes (X)$0$0$0
DEREK RAPP
PRESIDENT AND CEO50.00.0$725,000$0$48,715Yes (X)
SANDRA HIJIKATA
CHIEF DEV OFFICER & ASST. SECY50.00.0$368,333$0$18,280Yes (X)
MARK GREENE
CFO & ASST. TRES50.00.0$363,125$0$22,288Yes (X)
JILL CLARK
CHIEF OF STAFF & ASST. SECY50.00.0$240,831$0$14,703Yes (X)
JONATHAN R BEHR
MANAGING DIRECTOR JDRF-T1D FND50.00.0$25,000$0$0Yes (X)
JULIA GREENSTEIN
VP RESEARCH50.00.0$282,800$0$14,613Yes (X)
AARON KOWALSKI
CHIEF MISSION OFFICER50.00.0$350,000$0$35,661Yes (X)
RICHARD INSEL ENDED 63016
CHIEF SCIENTIFIC OFFICER50.00.0$605,102$0$27,345Yes (X)
MARGO LUCERO
SVP CORPORATE DEVELOPMENT50.00.0$268,000$0$38,273Yes (X)
STEVEN GRIFFEN MD
SVP RESEARCH50.00.0$377,033$0$42,547Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$3,605,224TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$262,425TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K149IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmProvince Or StateContractorAddress/ForeignAddress/ProvinceOrStateNmCountryContractorAddress/ForeignAddress/CountryCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCd
SIX DEGREES MEDICAL CONSULTING
175 BLOOR STTORONTO0CAFACULTY TRAINING$578,850
10UP LLC
WEB DEVELOPMENT$567,9812765 CARRADALE DRROSEVILLECA95661
CDS GLOBAL
3RD PARTY LOCK BOX$542,6501901 BELL AVEDES MOINESIA50315
STRAIGHTLINE INTERNATIONAL
PROGRAMMING SERVICES$457,810107 GRAND STREET 6NEW YORKNY10013
STOKES AUCTION GROUP
AUCTIONEER SERVICES$350,750740 MUNEVAR DRCARIDIFF BY THE SEACA92007
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K39CntrctRcvdGreaterThan100KCnt
Federated Campaigns$4,488,030FederatedCampaignsAmt
Fundraising$127,671,682FundraisingAmt
All Other Contributions$67,737,140AllOtherContributionsAmt
Noncash Contributions$17,224,248NoncashContributionsAmt
Total Contributions$199,896,852TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$593,975TotalRevenueColumnAmt
Unrelated Business Revenue$45,150UnrelatedBusinessRevenueAmt
Exclusion$548,825ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$1,017,000SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$383,706SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$633,294SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$633,294TotalRevenueColumnAmt
Exclusion$633,294ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$27,152,973FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$127,671,682ContriRptFundraisingEventAmt
Fundraising Direct Expenses$27,152,973FundraisingDirectExpensesAmt
Gaming Gross Income$1,106,452GamingGrossIncomeAmt
Gaming Direct Expenses$259,790GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$846,662TotalRevenueColumnAmt
Exclusion$846,662ExclusionAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMISCELLANEOUS PROGRAM REVENUEDesc
Business900099BusinessCd
Total Revenue Column$283,014TotalRevenueColumnAmt
Exclusion$283,014ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$283,014OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$202,253,797TotalRevenueColumnAmt
Unrelated Business Revenue$45,150UnrelatedBusinessRevenueAmt
Exclusion$2,311,795ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$56,018,820TotalAmt
Program Services$56,018,820ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$22,990,836TotalAmt
Program Services$22,990,836ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,784,272TotalAmt
Program Services$1,138,366ProgramServicesAmt
Management And General$231,955ManagementAndGeneralAmt
Fundraising$413,951FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$108,774TotalAmt
Program Services$74,292ProgramServicesAmt
Management And General$14,141ManagementAndGeneralAmt
Fundraising$20,341FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$58,996,885TotalAmt
Program Services$37,635,118ProgramServicesAmt
Management And General$7,669,595ManagementAndGeneralAmt
Fundraising$13,692,172FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$1,467,676TotalAmt
Program Services$936,377ProgramServicesAmt
Management And General$190,798ManagementAndGeneralAmt
Fundraising$340,501FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$8,952,280TotalAmt
Program Services$5,711,555ProgramServicesAmt
Management And General$1,163,796ManagementAndGeneralAmt
Fundraising$2,076,929FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$4,037,397TotalAmt
Program Services$2,794,875ProgramServicesAmt
Management And General$646,918ManagementAndGeneralAmt
Fundraising$595,604FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$1,475,007TotalAmt
Program Services$1,035,136ProgramServicesAmt
Management And General$134,882ManagementAndGeneralAmt
Fundraising$304,989FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$673,601TotalAmt
Program Services$569,193ProgramServicesAmt
Management And General$33,680ManagementAndGeneralAmt
Fundraising$70,728FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$233,403TotalAmt
Program Services$197,226ProgramServicesAmt
Management And General$11,670ManagementAndGeneralAmt
Fundraising$24,507FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$623,411TotalAmt
Program Services$623,411ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$452,370TotalAmt
Management And General$452,370ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$3,166,685TotalAmt
Program Services$2,675,849ProgramServicesAmt
Management And General$158,334ManagementAndGeneralAmt
Fundraising$332,502FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$5,167,896TotalAmt
Program Services$2,756,198ProgramServicesAmt
Management And General$432,525ManagementAndGeneralAmt
Fundraising$1,979,173FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$1,188,854TotalAmt
Program Services$722,823ProgramServicesAmt
Management And General$205,672ManagementAndGeneralAmt
Fundraising$260,359FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$3,941,474TotalAmt
Program Services$2,396,416ProgramServicesAmt
Management And General$681,875ManagementAndGeneralAmt
Fundraising$863,183FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$8,313,000TotalAmt
Program Services$5,026,204ProgramServicesAmt
Management And General$1,439,436ManagementAndGeneralAmt
Fundraising$1,847,360FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$2,413,804TotalAmt
Program Services$1,734,318ProgramServicesAmt
Management And General$229,794ManagementAndGeneralAmt
Fundraising$449,692FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$2,696,865TotalAmt
Program Services$1,966,015ProgramServicesAmt
Management And General$256,202ManagementAndGeneralAmt
Fundraising$474,648FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$4,629,902TotalAmt
Program Services$2,814,980ProgramServicesAmt
Management And General$800,973ManagementAndGeneralAmt
Fundraising$1,013,949FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$524,072TotalAmt
Program Services$318,636ProgramServicesAmt
Management And General$90,664ManagementAndGeneralAmt
Fundraising$114,772FundraisingAmt

Other Expenses OtherExpensesGrp (3 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
OUTREACH EXPENSES$2,021,589$1,286,944$277,766$456,879
DUES & FEES$1,492,960$950,418$205,133$337,409
OTHER MISC EXPENSES$417,499$265,780$57,364$94,355

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$193,789,332TotalAmt
Program Services$152,639,786ProgramServicesAmt
Management And General$15,385,543ManagementAndGeneralAmt
Fundraising$25,764,003FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$2,105,461TotalAmt
Program Services$743,506ProgramServicesAmt
Management And General$111,868ManagementAndGeneralAmt
Fundraising$1,250,087FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$30,314,175BOYAmt
EOY$23,695,495EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$34,391,736BOYAmt
EOY$30,545,972EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$25,415,000BOYAmt
EOY$28,143,186EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$15,598,016BOYAmt
EOY$14,274,402EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$5,000,000EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$4,604,817BOYAmt
EOY$5,592,386EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$31,236,775LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$21,516,895LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$13,589,735BOYAmt
EOY$9,719,880EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$34,442,190BOYAmt
EOY$38,164,626EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$36,283,061BOYAmt
EOY$39,867,626EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$2,454,398BOYAmt
EOY$3,750,000EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$197,093,128BOYAmt
EOY$198,753,573EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$16,335,885BOYAmt
EOY$16,729,137EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$105,778,368BOYAmt
EOY$94,060,180EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$8,340,978BOYAmt
EOY$7,934,693EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,742,623BOYAmt
EOY$2,661,059EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$133,197,854BOYAmt
EOY$121,385,069EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$24,131,379BOYAmt
EOY$39,586,000EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$32,690,094BOYAmt
EOY$30,441,504EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$7,073,801BOYAmt
EOY$7,341,000EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$63,895,274BOYAmt
EOY$77,368,504EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$197,093,128BOYAmt
EOY$198,753,573EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$8,464,465ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$5,008,765NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$196,010,663CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$210,068,935CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$198,918,214CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$196,804,267CurrentTaxYearMinus1YearAmt
Current Tax Year$199,896,852CurrentTaxYearAmt
Total$1,001,698,931TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$196,010,663CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$210,068,935CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$198,918,214CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$196,804,267CurrentTaxYearMinus1YearAmt
Current Tax Year$199,896,852CurrentTaxYearAmt
Total$1,001,698,931TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$5,476,665SubstantialContributorsTotAmt
Public Support Total170$996,222,266PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,015,080CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,646,615CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$987,577CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$465,379CurrentTaxYearMinus1YearAmt
Current Tax Year$548,825CurrentTaxYearAmt
Total$5,663,476TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$29,449CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$6,810CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,516CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$112,437CurrentTaxYearMinus1YearAmt
Current Tax Year$33,150CurrentTaxYearAmt
Total$184,362TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$74,636CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$136,667CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$256,146CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$94,769CurrentTaxYearMinus1YearAmt
Current Tax Year$283,014CurrentTaxYearAmt
Total$845,232TotalAmt
FieldValueIRS element (for citing)
Total Support$1,008,392,001TotalSupportAmt
Public Support CY1700.98793PublicSupportCY170Pct
Public Support PY1700.98424PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Total Grassroots LobbyingTotalGrassrootsLobbyingGrp
Total Direct LobbyingTotalDirectLobbyingGrp
Total Lobbying ExpendTotalLobbyingExpendGrp
Other Exempt Purpose ExpendOtherExemptPurposeExpendGrp
Total Exempt Purpose ExpendTotalExemptPurposeExpendGrp
Lobbying Nontaxable AmountLobbyingNontaxableAmountGrp
Grassroots NontaxableGrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp
Form4720 FiledfalseForm4720FiledInd
VolunteersYes (true)VolunteersInd
Paid Staff Or ManagementYes (true)PaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Mailings MembersYes (true)MailingsMembersInd
Mailings Members$73,969MailingsMembersAmt
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Grants Other OrganizationsYes (true)GrantsOtherOrganizationsInd
Grants Other Organizations$210GrantsOtherOrganizationsAmt
Direct Contact LegislatorsYes (true)DirectContactLegislatorsInd
Direct Contact Legislators$509,616DirectContactLegislatorsAmt
Rallies DemonstrationsYes (true)RalliesDemonstrationsInd
Rallies Demonstrations$202,384RalliesDemonstrationsAmt
Other ActivitiesfalseOtherActivitiesInd
Total Lobbying Expenditures$786,179TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceJDRF LOBBYING ACTIVITIESFormAndLineReferenceDesc
ExplanationFORM 990- SCH-C- GENERAL STATEMENT OF ACTIVITIES JDRF is the leading global organization funding type 1 diabetes (T1D) research. Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. Through research and advocacy, JDRF is accelerating progress on the most promising opportunities to cure, prevent and treat T1D and its complications. JDRF's advocacy includes lobbying activity to ensure Congress continues to invest in critically important medical research and puts in place policies to advance the discovery, development, and delivery of better therapies for T1D. JDRF has been instrumental in securing the renewal of the Special Diabetes Program, which provides $150MM annually for T1D research at the National Institutes of Health. JDRF staff and volunteers communicate with government officials through email, phone calls, and meetings, to educate them on issues and encourage the advancement of legislation.ExplanationTxt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,176,427BeginningYearBalanceAmt
Investment Earnings Or Losses$367,446InvestmentEarningsOrLossesAmt
Other Expenditures$102,000OtherExpendituresAmt
End Year Balance$7,441,873EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,141,514BeginningYearBalanceAmt
Investment Earnings Or Losses$37,913InvestmentEarningsOrLossesAmt
Other Expenditures$3,000OtherExpendituresAmt
End Year Balance$7,176,427EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,426,222BeginningYearBalanceAmt
Investment Earnings Or Losses$11,292InvestmentEarningsOrLossesAmt
Other Expenditures$296,000OtherExpendituresAmt
End Year Balance$7,141,514EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,837,461BeginningYearBalanceAmt
Investment Earnings Or Losses$625,761InvestmentEarningsOrLossesAmt
Other Expenditures$37,000OtherExpendituresAmt
End Year Balance$7,426,222EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,728,240BeginningYearBalanceAmt
Contributions$100,000ContributionsAmt
Investment Earnings Or Losses$9,221InvestmentEarningsOrLossesAmt
End Year Balance$6,837,461EndYearBalanceAmt
FieldValueIRS element (for citing)
Prmnnt Endowment Balance EOY0.98640PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.01360TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$4,722,775OtherCostOrOtherBasisAmt
Depreciation$3,278,539DepreciationAmt
Book Value$1,444,236BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$26,514,000OtherCostOrOtherBasisAmt
Depreciation$18,238,356DepreciationAmt
Book Value$8,275,644BookValueAmt
FieldValueIRS element (for citing)
Other Land BuildingsOtherLandBuildingsGrp
Total Book Value Land Buildings$9,719,880TotalBookValueLandBuildingsAmt
Financial DerivativesFinancialDerivativesGrp
Closely Held Equity InterestsCloselyHeldEquityInterestsGrp

Other Securities OtherSecuritiesGrp (2 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
HEDGE FUNDS$22,477,058F
US-NON-PUBLIC INVESTMENT FUNDS$17,390,568F
FieldValueIRS element (for citing)
Total Book Value Securities$39,867,626TotalBookValueSecuritiesAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescSPLIT INTEREST CHRT RMDR TRUSTDesc
Amt$2,661,059Amt
FieldValueIRS element (for citing)
Total Liability$2,661,059TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$206,810,192TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$5,008,765NetUnrealizedGainsInvstAmt
Revenue Not Reported$5,008,765RevenueNotReportedAmt
Revenue Subtotal$201,801,427RevenueSubtotalAmt
Investment Expenses Not Incld$452,370InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$452,370RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$202,253,797TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$193,336,962TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal$193,336,962ExpensesSubtotalAmt
Investment Expenses Not Incld2$452,370InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$452,370ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$193,789,332TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
ORGANIZATION'S ENDOWMENT FUNDSFORM 990, PART X, LINE 28 & 29 & SCH D, PART V THE ORGANIZATION UTILIZES EARNINGS ON ENDOWMENT FUNDS IN THE MANNER SPECIFIED BY THE DONOR AND/OR FOR SUPPORTING THE ORGANIZATIONS GENERAL EXEMPT PURPOSE.
INCOME TAX POSITION OF JDRF INT.990 SCH-D, PART X, LINE 2 JDRF IS A NOT FOR PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501 (C) (3) OF THE INTERNAL REVENUE CODE AND IS ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA. INCOME GENERATED FROM ACTIVITIES UNRELATED TO JDRFS EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. INCOME TAX LIABILITIES ARE RECOGNIZED WHEN SUCH POSITIONS ARE QUANTIFIABLE AND LIKELY TO BE REALIZED. UNRELATED BUSINESS INCOME TAX LIABILITY WAS INSIGNIFICANT FOR THE YEARS ENDING JUNE 30, 2017 AND 2016.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmtOfficesOfficesCntEmployeeEmployeeCnt
North AmericaGrantmakingRESEARCH GRANTS$4,305,000
Central America and the CaribbeanInvestmentsINVESTMENTS$8,461,823
Europe (Including Iceland and Greenland)Program ServicesRESEARCH SUPPORT$375,45322
East Asia and the PacificGrantmakingRESEARCH GRANTS$3,734,400
Middle East and North AfricaGrantmakingRESEARCH GRANTS$1,472,215
Europe (Including Iceland and Greenland)GrantmakingRESEARCH GRANTS$13,479,221
FieldValueIRS element (for citing)
Subtotal Offices2SubtotalOfficesCnt
Subtotal Employees2SubtotalEmployeesCnt
Total Office2TotalOfficeCnt
Total Employee2TotalEmployeeCnt
Subtotal Spent$31,828,112SubtotalSpentAmt
Total Spent$31,828,112TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (65 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtDescription Of Non Cash AsstDescriptionOfNonCashAsstTxtValuation Method UsedValuationMethodUsedDesc
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$50,000CHECK/WIREN/AN/A
North America$61,847CHECK/WIREN/AN/A
Middle East and North Africa$770,360CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$777,248CHECK/WIREN/AN/A
Middle East and North Africa$250,748CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$907,009CHECK/WIREN/AN/A
East Asia and the Pacific$197,513CHECK/WIREN/AN/A
East Asia and the Pacific$468,226CHECK/WIREN/AN/A
North AmericaIMMUNE THERAPIES$483,604CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$63,388CHECK/WIREN/AN/A
East Asia and the Pacific$145,000CHECK/WIREN/AN/A
North America$488,106CHECK/WIREN/AN/A
North America$923,269CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$508,049CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$441,922CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$249,673CHECK/WIREN/AN/A
North America$436,051CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$931,478CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$248,798CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$378,465CHECK/WIREN/AN/A
East Asia and the Pacific$333,716CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$110,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$100,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$650,000CHECK/WIREN/AN/A
North AmericaIMMUNE THERAPIES$190,250CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$379,999CHECK/WIREN/AN/A
North AmericaIMMUNE THERAPIES$1,000,000CHECK/WIREN/AN/A
East Asia and the Pacific$1,199,144CHECK/WIREN/AN/A
North America$62,640CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$149,432CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$331,590CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$149,614CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$691,243CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$169,358CHECK/WIREN/AN/A
North America$92,277CHECK/WIREN/AN/A
East Asia and the PacificARTIFICIAL PANCREAS$250,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$232,580CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$2,007,864CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THEPAPIES$440,766CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$265,937CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$229,626CHECK/WIREN/AN/A
East Asia and the PacificIMMUNE THERAPIES$150,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$388,107CHECK/WIREN/AN/A
Middle East and North AfricaIMMUNE THERAPIES$451,867CHECK/WIREN/AN/A
East Asia and the Pacific$250,000CHECK/WIREN/AN/A
North AmericaIMMUNE THERAPIES$367,768CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$681,170CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$249,694CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL$125,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$90,787CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$262,419CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL$65,231CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$118,496CHECK/WIREN/AN/A
North AmericaCOMPLICATIONS$118,639CHECK/WIREN/AN/A
East Asia and the PacificIMMUNE THERAPIES$499,993CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$79,936CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$99,532CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL$125,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)REGENERATION$620,000CHECK/WIREN/AN/A
East Asia and the PacificIMMUNE THERAPIES$374,920CHECK/WIREN/AN/A
North AmericaIMMUNE THERAPIES$80,550CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$232,154CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$623,261CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$113,157CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPPIES$150,000CHECK/WIREN/AN/A
FieldValueIRS element (for citing)
Total501c3 Org50Total501c3OrgCnt
Total Other Org15TotalOtherOrgCnt
Transfer To Foreign CorpYes (true)TransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipYes (true)ForeignCorpOwnershipInd
Passive Foreign Investmest CoYes (true)PassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceGRANT MONITORING PROCEDURESFormAndLineReferenceDesc
ExplanationSCH-F PART I LINE 2 Research grants are awarded by JDRFs Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRFs goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice, evaluation, research progress reports, helping disseminate research results and reviewing research expenditures versus agreed budgets.ExplanationTxt

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Solicitation Of Govt GrantsYes (X)SolicitationOfGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

FieldValueIRS element (for citing)
PersonInsurance Auto AuctionsPersonNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO Box 2365AddressLine1Txt
CityFair OaksCityNm
State AbbreviationCAStateAbbreviationCd
ZIP95628ZIPCd
FieldValueIRS element (for citing)
ActivityCAR DONATIONActivityTxt
Fundraiser Control Of FundsYes (true)FundraiserControlOfFundsInd
Gross Receipts$260,800GrossReceiptsAmt
Retained By Contractor$95,118RetainedByContractorAmt
Net To Organization$165,682NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Gross Receipts$260,800TotalGrossReceiptsAmt
Total Retained By Contractors$95,118TotalRetainedByContractorsAmt
Total Net To Organization$165,682TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDELicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesIDLicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesIALicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesMTLicensedStatesCd
Licensed StatesNELicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesSDLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1SEATTLE GALAEvent1Nm
Gross Receipts Event1$2,651,726GrossReceiptsEvent1Amt
Charitable Contri Event1$1,970,220CharitableContriEvent1Amt
Gross Revenue Event1$681,506GrossRevenueEvent1Amt
Non Cash Prizes Event1$17,308NonCashPrizesEvent1Amt
Rent Facility Costs Event1$216,426RentFacilityCostsEvent1Amt
Food And Beverage Event1$15,310FoodAndBeverageEvent1Amt
Entertainment Event1$242,509EntertainmentEvent1Amt
Other Direct Expenses Event1$64,290OtherDirectExpensesEvent1Amt
Event2ILLINOIS GALAEvent2Nm
Gross Receipts Event2$4,927,110GrossReceiptsEvent2Amt
Charitable Contri Event2$4,228,565CharitableContriEvent2Amt
Gross Revenue Event2$698,545GrossRevenueEvent2Amt
Rent Facility Costs Event2$40,547RentFacilityCostsEvent2Amt
Food And Beverage Event2$230,419FoodAndBeverageEvent2Amt
Entertainment Event2$318,066EntertainmentEvent2Amt
Other Direct Expenses Event2$9,364OtherDirectExpensesEvent2Amt
Other Events Total375OtherEventsTotalCnt
Gross Receipts Other Events$147,245,819GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$121,472,897CharitableContriOtherEventsAmt
Gross Revenue Other Events$25,772,922GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events$79,306NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$3,435,039RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$2,529,307FoodAndBeverageOtherEventsAmt
Entertainment Other Events$3,373,875EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$16,581,207OthDirectExpnssOtherEventsAmt
Gross Receipts Total$154,824,655GrossReceiptsTotalAmt
Charitable Contributions Tot$127,671,682CharitableContributionsTotAmt
Gross Revenue Total Events$27,152,973GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events$96,614NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$3,692,012RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$2,775,036FoodAndBeverageTotalEventsAmt
Entertainment Total Events$3,934,450EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$16,654,861OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$27,152,973DirectExpenseSummaryEventsAmt

Gaming Information GamingInformationGrp

FieldValueIRS element (for citing)
Gross Revenue Other Gaming$1,106,452GrossRevenueOtherGamingAmt
Cash Prizes Other Gaming$10,000CashPrizesOtherGamingAmt
Non Cash Prizes Other Gaming$249,790NonCashPrizesOtherGamingAmt
Volunteer Labor Other GamingfalseVolunteerLaborOtherGamingInd
Gross Revenue Total Gaming$1,106,452GrossRevenueTotalGamingAmt
Cash Prizes Total Gaming$10,000CashPrizesTotalGamingAmt
Non Cash Prizes Total Gaming$249,790NonCashPrizesTotalGamingAmt
Direct Expense Summary Gaming$259,790DirectExpenseSummaryGamingAmt
Net Gaming Income Summary$846,662NetGamingIncomeSummaryAmt
FieldValueIRS element (for citing)
States Where Gaming ConductedALStatesWhereGamingConductedCd
States Where Gaming ConductedAKStatesWhereGamingConductedCd
States Where Gaming ConductedAZStatesWhereGamingConductedCd
States Where Gaming ConductedARStatesWhereGamingConductedCd
States Where Gaming ConductedCAStatesWhereGamingConductedCd
States Where Gaming ConductedCOStatesWhereGamingConductedCd
States Where Gaming ConductedCTStatesWhereGamingConductedCd
States Where Gaming ConductedDEStatesWhereGamingConductedCd
States Where Gaming ConductedDCStatesWhereGamingConductedCd
States Where Gaming ConductedFLStatesWhereGamingConductedCd
States Where Gaming ConductedGAStatesWhereGamingConductedCd
States Where Gaming ConductedHIStatesWhereGamingConductedCd
States Where Gaming ConductedIDStatesWhereGamingConductedCd
States Where Gaming ConductedILStatesWhereGamingConductedCd
States Where Gaming ConductedINStatesWhereGamingConductedCd
States Where Gaming ConductedIAStatesWhereGamingConductedCd
States Where Gaming ConductedKSStatesWhereGamingConductedCd
States Where Gaming ConductedKYStatesWhereGamingConductedCd
States Where Gaming ConductedLAStatesWhereGamingConductedCd
States Where Gaming ConductedMEStatesWhereGamingConductedCd
States Where Gaming ConductedMDStatesWhereGamingConductedCd
States Where Gaming ConductedMAStatesWhereGamingConductedCd
States Where Gaming ConductedMIStatesWhereGamingConductedCd
States Where Gaming ConductedMNStatesWhereGamingConductedCd
States Where Gaming ConductedMSStatesWhereGamingConductedCd
States Where Gaming ConductedMOStatesWhereGamingConductedCd
States Where Gaming ConductedMTStatesWhereGamingConductedCd
States Where Gaming ConductedNEStatesWhereGamingConductedCd
States Where Gaming ConductedNVStatesWhereGamingConductedCd
States Where Gaming ConductedNHStatesWhereGamingConductedCd
States Where Gaming ConductedNJStatesWhereGamingConductedCd
States Where Gaming ConductedNMStatesWhereGamingConductedCd
States Where Gaming ConductedNYStatesWhereGamingConductedCd
States Where Gaming ConductedNCStatesWhereGamingConductedCd
States Where Gaming ConductedNDStatesWhereGamingConductedCd
States Where Gaming ConductedOHStatesWhereGamingConductedCd
States Where Gaming ConductedOKStatesWhereGamingConductedCd
States Where Gaming ConductedORStatesWhereGamingConductedCd
States Where Gaming ConductedPAStatesWhereGamingConductedCd
States Where Gaming ConductedRIStatesWhereGamingConductedCd
States Where Gaming ConductedSCStatesWhereGamingConductedCd
States Where Gaming ConductedSDStatesWhereGamingConductedCd
States Where Gaming ConductedTNStatesWhereGamingConductedCd
States Where Gaming ConductedTXStatesWhereGamingConductedCd
States Where Gaming ConductedUTStatesWhereGamingConductedCd
States Where Gaming ConductedVTStatesWhereGamingConductedCd
States Where Gaming ConductedVAStatesWhereGamingConductedCd
States Where Gaming ConductedWAStatesWhereGamingConductedCd
States Where Gaming ConductedWVStatesWhereGamingConductedCd
States Where Gaming ConductedWIStatesWhereGamingConductedCd
States Where Gaming ConductedWYStatesWhereGamingConductedCd
LicensedYes (true)LicensedInd
License Suspended EtcfalseLicenseSuspendedEtcInd
Gaming With NonmembersfalseGamingWithNonmembersInd
Member Of Other EntityfalseMemberOfOtherEntityInd
Gaming Other Facility1.00000GamingOtherFacilityPct
Individual With BooksGARY CURTOIndividualWithBooksNm

Persons With Books US Address PersonsWithBooksUSAddress

FieldValueIRS element (for citing)
Address Line126 BROADWAY-14TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd
FieldValueIRS element (for citing)
Cntrct With3rd Prty For Game RevfalseCntrctWith3rdPrtyForGameRevInd
Gaming Manager PersonGARY CURTO TAX MANAGER -JDRFGamingManagerPersonNm
Gaming Manager Compensation$0GamingManagerCompensationAmt
Gaming Manager Services ProvFILING GAMING APPLICATIONS AND REPORTSGamingManagerServicesProvTxt
Gaming Manager Is EmployeeYes (X)GamingManagerIsEmployeeInd
Charitable Distribution RqrYes (true)CharitableDistributionRqrInd
Distributed$846,662DistributedAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE G, PART I, LINE 2FormAndLineReferenceDesc
ExplanationINSURANCE AUTO AUCTIONS LLC IS A STATE LICENSED PROFESSIONAL FUNDRAISER THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CONTACT THE COMPANY DIRECTLY THROUGH A TOLL FREE NUMBER TO COORDINATE THE DONATION, FOLLOWING WHICH INSURANCE AUTO AUCTIONS HANDLES ALL REQUIRED IRS 1098C REPORTING. FOR THE PERIOD ENDING 6/30/17, THE CAR PROGRAM RAISED $260,800 WITH TOTAL EXPENSES OF $95,118 WITH THE NET PROCEEDS OF $165,682 PROVIDED DIRECTLY TO JDRF. JDRF PAYS NO ADDITIONAL EXPENSES OR FEES TO INSURANCE AUTO AUCTIONS FOR THIS PROGRAM.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (84 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtValuation Method UsedValuationMethodUsedDescNon Cash AssistanceNonCashAssistanceDescPurpose Of GrantPurposeOfGrantTxt
BENAROYA RESEARCH INST AT VIRGINIA MASON
1201 9TH AVESEATTLEWA98101910653422501(C)3$2,691,474N/AN/A
BD TECHNOLOGIES
DAVIS DRIVERESEARCH TRIANGLE PKNC27709999999999$400,000N/AN/A
ANN AND ROBERT LURIE CHILDREN'S HOSPITAL
320 NORTH AVEPITTSBURGHPA15212362170833501(C)3$10,000N/AN/A
CAPILLARY BIOMEDICAL
56 HAVENWOODIRVINECA92614464787731$130,000N/AN/AIMMUNE THERAPIES
CASE WESTERN UNIVERSITY
10900 EUCLID AVECLEVELANDOH44106341018992501(C)3$170,816N/AN/AIMMUNE THERAPIES
UNIVERSITY OF ARIZONA
PO BOX 210TUCSONAZ85721113661893501(C)3$649,113N/AN/A
CHILDREN'S HOSPITAL OF PHILADELPHIA
3401 CIVIC CENTER BLVDPHILPA19014231352166501(C)3$108,555N/AN/AIMMUNE THERAPIES
CRITICAL PATH INSTITUTE
1730 EAST RIVER ROADTUCSONAZ85718201991334$124,000N/AN/A
INDIANA UNIVERSITY
620 UNION DRINDIANAPOLISIN46202356018940501(C)3$1,072,836N/AN/A
BETH ISRAEL MEDICAL CENTER
1 BROOKLINE AVEBOSTONMA92121135564934501(C)3$506,572N/AN/A
JOSLIN DIABETES CENTER
1 JOSLIN PLBOSTONMA02215042203836501(C)3$1,109,271N/AN/A
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
25 AMES STCAMBRIDGEMA02467042103594501(C)3$815,502N/AN/A
INDIANA BIOSCIENCES RES INST
1345 W 16TH STREETINDIANAPOLISIN46202462882271501(C)3$150,000N/AN/A
CALIFORNIA INST FOR BIOMEDICAL RESEARCH
11119 NTORRY PINES RDLAJOLLACA92037956047739501(C)3$2,851,029N/AN/A
EMORY UNIVERSITY
69 JESSE HILL JR DRIVEATLANTAGA30322580566256501(C)3$490,526N/AN/A
MAYO CLINIC
1216 2ND STREETROCHESTERMN55902411405254501(C)3$326,202N/AN/AIMMUNE THERAPIES
GEORGIA TECH RESEARCH CORP
505 TENTH STREETATLANTAGA30332580603146501(C)3$180,695N/AN/AIMMUNE THERAPIES
STANFORD UNIVERSITY
300 PASTEUR DRPALA ALTOCA94305941156365501(C)3$772,523N/AN/A
JOHNS HOPKINS UNIVERSITY
733 N BROADWAYBALTIMOREMD21205520595110501(C)3$499,991N/AN/AIMMUNE THERAPIES
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
550 FIRST AVENUENEW YORKNY10016135562309501(C)3$510,000N/AN/A
NATIONAL JEWISH HEALTH
601 EAST 18TH STREETDENVERCO80206742044647501(C)3$250,000N/AN/A
NORTH CAROLINA STATE UNIVERSITY
2701 SULLIVAN DRIVERALEIGHNC27695440680117501(C)3$540,000N/AN/A
NEW YORK STEM CELL FOUNDATION
619 WEST 54TH STREETNEW YORKNY10019202905531501(C)3$200,000N/AN/A
BECKMAN RESEARCH INST OF THE CITY OF HOPE
1500 EAST DUARTE ROADDUARTECA91010953432210501(C)3$1,171,777N/AN/A
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSONPORTLANDOR97239237083114501(C)3$464,937N/AN/AIMMUNE THERAPIES
LEXICON PHARMACEUTICALS
8800 TECH FOREST PLTHE WOODLANDSTX77381760474179$400,000N/AN/A
PACIFIC DIABETES TECHNOLOGIES
12154 SW GARDEN PLACEPORTLANDOR97223999999999501(C)3$178,788N/AN/A
UNIVERSITY OF FLORIDA
1600 SW ARCHER ROADGAINESVILLEFL32610590974739501(C)3$3,291,730N/AN/A
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVE NORTHWORCESTERMA01605043167352501(C)3$70,815N/AN/A
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
1450 NW 10TH AVEMIAMIFL33136590624458501(C)3$1,967,148N/AN/A
UNIVERSITY OF VIRGINIA
104 MIDMONT LNCHARLOTTESVILLEVA22902416042488501(C)3$334,651N/AN/A
UNIVERSITY OF MICHIGAN
1331 EAST ANN STREETANN ARBORMI48109386006309501(C)3$894,233N/AN/A
PACIFIC NORTHWEST RESEARCH INSTITUTE
720 BROADWAYSEATTLEWA98122910667886501(C)3$40,233N/AN/AIMMUNE THERAPIES
TETRAGENETICS
91 MYSTIC STREETARLINGTONMA02474043784099$710,000N/AN/AIMMUNE THERAPIES
UNIVERSITY OF CALIFORNIA
3333 CA STSAN FRANCISCOCA94122956006143501(C)3$5,968,555N/AN/A
UNIVERSITY OF WISCONSIN-MADISON
21 NORTH PARKMADISONWI53706396006492501(C)3$650,000N/AN/A
UT SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVDDALLASTX75390756002868501(C)3$738,690N/AN/A
VANDERBILT UNIVERSITY MEDICAL CENTER
1211 MEDICAL CENTER DRNASHVILLETN37232620476822501(C)3$388,079N/AN/A
BAYLOR COLLEGE OF MEDICINE-RESEARCH INSTITUTE
3500 GASTON AVEDALLASTX75246751921898501(C)3$246,356N/AN/A
BROAD INSTITUTE
7 CAMBRIDGE CENTERCAMBRIDGEMA02142263428781501(C)3$285,342N/AN/A
DUKE UNIVERSITY
4321 MEDICAL PARK DRDURHAMNC27704560532129501(C)3$368,992N/AN/A
UNIVERSITY OF CONNECTICUT
69 N EAGLEVILLESTORRSCT06269066085975501(C)3$249,999N/AN/AIMMUNE THERAPIES
UNIVERSITY OF SOUTH FLORIDA
4202 E FOWLER AVETAMPAFL33620590879015501(C)3$423,532N/AN/AIMMUNE THERAPIES
JAEB CENTER FOR HEALTH RESEARCH FND
15310 Amberly DriveTAMPAFL33647593187624501(C)3$3,950,383N/AN/A
VIACYTE
3550 GENERAL ATOMICSSAN DIEGOCA92121330884172$2,000,000N/AN/A
COLUMBIA UNIVERSITY
PO BOX 29789NEW YORKNY10087135598093501(C)3$327,912N/AN/A
YALE UNIVERSITY
PO BOX 209010NEW HAVENCT06520060646973501(C)3$861,255N/AN/AIMMUNE THERAPIES
UNIVERSITY OF ALABAMA
COLLEGE DRIVEBIRMINGHAMAL35294636001138501(C)3$627,092N/AN/A
NORTHWESTERN UNIVERSITY
633 CLARK STREETEVANSTONIL60208231352685501(C)3$922,961N/AN/A
DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVEBOSTONMA02115042263040501(C)3$60,816N/AN/ABETA CELL THERAPIES
SELECTA BIOSCIENCE INC
480 ARSENAL STREETWATERTOWNMA02472261622110$47,879N/AN/A
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVECHICAGOIL60637362177139501(C)3$249,998N/AN/A
ICAHN SCHOOL OF MEDICINE MOUNT SINAI
1 GUSTAVE L LEVY PLACENEW YORKNY10029136171197501(C)3$637,698N/AN/A
NOVARTIS INSTITUTE-GENOMICS
10675 JOHN HOPKINS DRSAN DIEGOCA92121223610512$504,565N/AN/A
ILLINOIS INSTITUTE OF TECHNOLOGY
3300 SOUTH FEDERAL STREETCHICAGOIL60616362170136501(C)3$246,082N/AN/A
UNIVERSITY OF MINNESOTA
80 SOUTH 8TH STREETMINNEAPOLISMN55455416007513501(C)3$1,149,643N/AN/A
JACKSON LABORATORY
600 MAIN STREETBAR HARBORME04609010211513501(C)3$62,640N/AN/A
RUTGERS THE STATE UNIVERSITY
175 UNIVERSITY AVENEWARKNJ07107462354111501(C)3$347,735N/AN/AIMMUNE THERAPIES
UNIVERSITY OF WASHINGTON
1401 15TH AVESEATTLEWA98195911486484501(C)3$543,444N/AN/A
WESTERN MICHIGAN UNIVERSITY
1903 W MICHIGAN ANEKALAMAZOOMI49008454135256501(C)3$127,088N/AN/A
CLEMSON UNIVERSITY
105 COLLINGS STCLEMSONSC29634157600025501(C)3$10,000N/AN/APREVENTION
DIABETOMICS
2345 AMBERBROOKHILLSBOROOR97006273132477$90,000N/AN/APREVENTION
OHIO STATE UNIVERSITY
281 W Lane AVECOLUMBUSOH43210611730890501(C)3$140,000N/AN/AARTIFICIAL PANCREAS
THE BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115042312909501(C)3$164,996N/AN/ACOMPLICATIONS
THOMAS JEFFERSON UNIVERSITY
125 S 9TH STREETPHILADELPHIAPA19019232829095501(C)3$110,000N/AN/AARTIFICIAL PANCREAS
TIDEPOOL
450 TOWNSEND STSAN FRANCISCOCA94107462302287$2,076,155N/AN/AARTIFICIAL PANCREAS
WAVE 80 BIOSCIENCES
2325 THIRD STREETSAN FRANCISCOCA94107020691818$80,000N/AN/APREVENTION
UNIVERSITY OF UTAH
201 PRESIDENTS CRSALT LAKE CITYUT84102876000525501(C)3$858,631N/AN/AGLUCOSE MODULATION
WAYNE STATE UNIVERSITY
5700 CASS AVEDETROITMI48201383555142501(C)3$269,856N/AN/AENCAPSULATED ISLETS
ALLEGHENY SINGER RESEARCH INST
320 E NORTH AVENUEPITTSBURGHPA15212251320493$249,999N/AN/ABETA CELL THERAPIES
HARVARD MEDICAL SCHOOL
200 LONGWOOD AVEBOSTONMA02115042103580501(C)3$883,862N/AN/AIMMUNE THERAPIES
PRODO LABORATORIES
27402 ALISO VIEJO PKYALISO VIEJOCA92656205534494$36,478N/AN/AIMMUNE THERAPIES
PROTOMER TECHNOLOGIES
430 S CATALINA AVEPASADENACA91106474206994$280,000N/AN/AIMMUNE THERAPIES
UNIVERSITY OF SOUTHERN CALIFORNIA
COLLEGE DRIVELOS ANGELESCA90089951642394501(C)3$362,454N/AN/AIMMUNE THERAPIES
UNIVERSITY OF COLORADO
PO BOX 6511DENVERCO80045846049811501(C)3$1,490,772N/AN/AIMMUNE THERAPIES
UNIVERSITY OF ILLINOIS
1200 HARRISONCHICAGOIL60612376006007501(C)3$236,202N/AN/AIMMUNE THERAPIES
UNITIO
11 AVENUE DE LAYFETTEBOSTONMA02111451623549$491,763N/AN/AIMMUNE THERAPIES
UNIVERSITY OF MARYLAND
COLLEGE PAR ROADCOLLEGE PARKMD20737522004514501(C)3$524,761N/AN/AIMMUNE THERAPIES
UNIVERSITY OF NEBRASKA
151 WHITTIERLINCOLNNE68503470379839501(C)3$247,021N/AN/AIMMUNE THERAPIES
UNIVERSITY OF TEXAS HEALTH SCIENCE
7703 FLOYD CURL DRIVESAN ANTONIOTX78229741586031501(C)3$95,000N/AN/AIMMUNE THERAPIES
WASHINGTON UNIVERSITY
One Brookings DriveSt LouisMO63130430653611501(C)3$708,716N/AN/AIMMUNE THERAPIES
UNIVERSITY OF KANSAS CENTER FOR RESEARCH
1200 SUNNYSIDE AVELAWRENCEKS66045480680117501(C)3$249,997N/AN/AIMMUNE THERAPIES
AUGUSTA UNIVERSITY RESEARCH INSTITUTE
1474 LANEY WALKER BLVDAUGUSTAGA30912581418202501(C)3$110,889N/AN/A
BOSTON HEALTH ECONOMICS INC
222 BERKLEY STREETBOSTONMA02116043311183$242,020N/AN/A
FieldValueIRS element (for citing)
Total501c3 Org68Total501c3OrgCnt
Total Other Org16TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceGRANT MONITORING PROCEDURESFormAndLineReferenceDesc
ExplanationSCH-I PART I LINE 2 Research grants are awarded by JDRFs Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRFs goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice, evaluation, research progress reports, helping disseminate research results and reviewing research expenditures versus agreed budgets.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Housing Allowance Or ResidenceYes (X)HousingAllowanceOrResidenceInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredfalseSubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (true)SeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (10 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt
DEREK RAPP
PRESIDENT AND CEO$582,000$0$0$143,000$0$12,337$36,378$773,715$0
JULIA GREENSTEIN
VP RESEARCH$264,800$0$0$18,000$0$12,337$2,276$297,413$0
AARON KOWALSKI
CHIEF MISSION OFFICER$300,000$7,912$27,749$385,661$50,000
SANDRA HIJIKATA
CHIEF DEV OFFICER & ASST. SECY$356,333$12,000$12,337$5,943$386,613
MARK GREENE
CFO & ASST. TRES$345,125$18,000$12,337$9,951$385,413
RICHARD INSEL ENDED 63016
CHIEF SCIENTIFIC OFFICER$319,352$285,750$12,337$15,008$632,447
JILL CLARK
CHIEF OF STAFF & ASST. SECY$227,421$4,410$10,828$3,875$255,534$9,000
MARGO LUCERO
SVP CORPORATE DEVELOPMENT$262,640$5,360$12,337$25,936$306,273
STEVEN GRIFFEN MD
SVP RESEARCH$376,433$600$12,337$30,210$419,580
JONATHAN R BEHR
MANAGING DIRECTOR JDRF-T1D FND$25,000$0$0$0$0$0$0$25,000$0$0$0$0

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
HOUSING ALLOWANCESCHEDULE J PART I, LINE 1A Derek Rapp, Pres & CEO, received a housing allowance as per the terms of his employment agreement. For the 2016 calendar year, the housing allowance provided to Derek Rapp was $75,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J, Part II, Col. (B) (III). Dr. Richard Insel, chief scientific officer, received a housing allowance as per the terms of his employment agreement. For the 2016 calendar year, the housing allowance provided to Dr. Insel was $25,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J,Part II, Col (B) (III).
OTHER REPORTABLE COMPENSATIONSCHEDULE J PART II, COL (B)(iii) DEREK RAPP RECEIVED TRAVEL & ALLOWANCE EXPENSES FOR THE 2016 CALENDAR YEAR, THE ALLOWANCE PROVIDED TO MR. RAPP WAS $50,000; SUCH AMOUNT WAS TREATED AS TAXABLE COMPENSATION AND INCLUDED IN HIS FORM W-2. THIS AMOUNT WAS ALSO REPORTED ON SCHEDULE J, PART II, COL (B)(iii).
NON-FIXED PAYMENTSFORM 990, SCHEDULE J, PART I, LINE 7 JDRF AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEES PERFORMANCE. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2, PART II, COL. (B) (II).
SEVERANCE PAYMENTSSCHEDULE J, PART I, LINE 4A DR. RICHARD INSEL RECEIVED A SEVERANCE PAYMENT OF $252,500 WHICH IS REPORTED ON SCHEDULE J, PART II, COL. (B)(III) OTHER REPORTABLE COMPENSATION.

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)

Relationship DescriptionRelationshipDescriptionTxtTransactionTransactionAmtTransactionTransactionDescSharing Of RevenuesSharingOfRevenuesInd
ELIZABETH KECKLER
DAUGHTER OF ELLEN LEAKE$86,773EMPLOYMENT AT JDRF INT.false
LINDSAY ALTMAN
DAUGHTER OF LISA ALTMAN$22,001EMPLOYMENT AT JDRF INT.false

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceBUSINESS TRANSACTIONFormAndLineReferenceDesc
ExplanationSCHEDULE L, PART IV, COLUMN B ELLEN LEAKE WAS THE BOARD VICE-CHAIR FOR YEAR END 6/30/2017 LISA ALTMAN WAS A JDRF BOARD MEMBER FOR YEAR END 6/30/2017 SCHEDULE L, PART IV, COLUMN C FOR EMPLOYEES LISTED, TOTAL COMPENSATION INCLUDES EMPLOYER PAID BENEFITSExplanationTxt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp

Cars And Other Vehicles CarsAndOtherVehiclesGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution8ContributionCnt
Noncash Contributions Rpt F990$249,790NoncashContributionsRptF990Amt
Method Of Determining RevenuesTICKET SALESMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution372ContributionCnt
Noncash Contributions Rpt F990$4,994,790NoncashContributionsRptF990Amt
Method Of Determining RevenuesNET PROCEEDS OF SALEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescMISC AUCTION ITEMS DONATEDDesc
Contribution27720ContributionCnt
Noncash Contributions Rpt F990$11,979,668NoncashContributionsRptF990Amt
Method Of Determining RevenuesFAIR MARKET VALUEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received1Form8283ReceivedCnt
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedYes (true)ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
THIRD PARTY ASSISTANCELINE 32B INSURANCE AUTO AUCTIONS LLC IS A THIRD PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CALL A TOLL FREE NUMBER AND THEY ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, INSURANCE AUTO AUCTIONS HANDLES ALL IRS 1098-C REPORTING. INSURANCE AUTO AUCTIONS IS A LICENSED PROFESSIONAL FUNDRAISER AND IS LICENSED IN THE STATES THAT REQUIRE IT TO REGISTER. FOR THE PERIOD ENDING 6/30/17, THE CAR PROGRAM LLC RAISED $260,800 WITH TOTAL EXPENSES OF $95,118. A NET CHECK IS PAID DIRECTLY TO JDRF. JDRF DOES NOT PAY INSURANCE AUTO AUCTIONS ANY EXPENSES OR FEES DIRECTLY. TOTAL NET REVENUE FOR FY-17 WAS $165,682.
NONCASH CONTRIBUTIONSFORM 990, SCHEDULE M, PAGE 1 TYPES OF PROPERTY AND THE AMOUNTS LISTED IN PART I LINES 6, 9, and 25 ARE THE ACTUAL AMOUNT THAT DONORS HAVE DONATED FOR VEHICLES, SECURITIES, AND MISC ITEMS THAT ARE SOLD AT VARIOUS AUCTIONS & RAFFLES.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
ORGANIZATION'S MISSIONFORM 990, PART III, LINE 1 JDRFs mission is to accelerate life-changing breakthroughs to cure, prevent and treat Type 1 Diabetes (T1D) and its complications. JDRF is the leading global organization focused on T1D research and is committed to funding the development of new therapies and treatments to keep people with T1D healthier, longer, until a cure is found. Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. JDRF works every day to change the reality of this life-threatening autoimmune disease for millions of people - and to prevent anyone else from contracting the disease - by funding research, advocating for government support of research and new therapies, ensuring new therapies and technologies come to market, and connecting and engaging the T1D community. JDRF has funded more than $2 billion in research to date and made significant progress in understanding and fighting the disease. JDRF has played a role in nearly every T1D therapeutic advance of the past four decades, including the FDA-approved hybrid closed-loop artificial pancreas system in September 2016. PART III: STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS LINE 4A ($79,009,656) RESEARCH GRANTS JDRF funds research with the greatest potential to cure, prevent and treat type 1 diabetes (T1D). Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. JDRF has committed more than $2 billion to this research since 1970. The full impact of JDRFs research investment extends well beyond direct funding. JDRF leverages partnerships with academia, industry and clinicians to ensure that the most promising research opportunities are funded and accelerated. JDRF also provides early stage funding to research projects, and the results of those projects often lead to follow-on participation from many other entities, including other non-for-profit funders and corporations. JDRF's research team is staffed by accomplished experts and leaders in the field of T1D science and medicine who guide the organization's funding efforts. JDRFs highest priority remains funding research to deliver a cure for T1D and its complications. At the same time, JDRF is focused on developing better treatments that will transform the way people with T1D treat the disease today to help them live healthier lives now and in the future. The foundation's diversified research portfolio includes the following therapy areas: Artificial Pancreas: Artificial pancreas systems use technology to replicate the operation of a normal human pancreas and are one of the most revolutionary advances in diabetes care since the discovery of insulin. These systems link continuous glucose monitors and insulin pumps to smart software so that the right amount of insulin is delivered at the right time. Glucose Control: Glucose-responsive insulins (GRIs), or smart insulins, promise to be a game-changer in blood-sugar management. GRIs will be the first-ever insulin formulation that turns on and off in response to blood sugar highs and lows. JDRF is also funding research that explores the benefits of combining novel or repurposed drugs with standard insulin therapy. Beta Cell Replacement: This therapy, also known as encapsulation, can be implanted to provide long-term relief from insulin dosing without the need for immune suppression. JDRF-supported scientists are improving biomaterials for encapsulation devices to protect implanted beta cells from autoimmune attack, among other strategies. Beta Cell Restoration: This drug or biologic-based therapy represents a full biological cure for people with T1D. It stimulates restoration of the bodys own beta cells and the capacity to produce insulin. We are repurposing drugs that may reduce beta cell stress and/or induce survival, as well as funding immune therapies that will stop the disease in its tracks. Complications: JDRF-funded research has already yielded new treatments for diabetic eye and kidney disease, the most common complications. Today, researchers are identifying biomarkers and accelerating the completion of clinical trials of potential treatments. Prevention: JDRF research has identified a number of potential triggers, including viruses and environmental conditions, which could open the door to new vaccines and other prevention strategies. The organization is also funding efforts to stall the progression of the disease in those at risk or newly diagnosed. For more information, visit jdrf.org/research. The JDRF T1D Fund (www.t1dfund.org), a wholly owned subsidiary of JDRF, is a venture philanthropy fund accelerating life-changing solutions to treat, prevent and cure T1D through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, pharma and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines into the hands of those living with T1D. The T1D Fund invests in whitespace opportunities and areas strategically aligned with JDRF, with an exclusive focus on the best commercial opportunities. All funds were deployed to directly support companies developing approaches to treat, prevent and cure T1D and are aligned with the JDRF mission. In accordance with GAAP, $7.1MM of the T1D Funds total investments for the FY17 period are reflected in the Balance Sheet (Part X) and not included within the organizations research-related mission expense. LINE 4B ($20,866,569) RESEARCH SUPPORT JDRF maintains an in-house team of skilled and credentialed scientific, policy and government relations professionals, each of whom plays a critical role in leading and supporting the research strategy and the disbursement of research funds from JDRF and others to create a world without type 1 diabetes (T1D). In their respective responsibilities, these professionals perform the functions of identifying, evaluating and influencing groundbreaking research being funded by JDRF, other foundations, governments and industry to achieve the organization's mission. These professionals also work with regulatory and policy officials to ensure research can proceed without delay and that research results are well understood by healthcare decision makers. As part of these efforts, JDRF organizes and funds scientific meetings, symposia, and conferences with the purpose of reviewing research proposals, ensuring that JDRF's research strategy is well aligned with the needs of the T1D community and allowing JDRF to provide scientific updates on the research it manages. JDRF also works with its external Research Advisory Committee (RAC), which is composed of professionals who are internationally renowned for their expertise in research as well as the care and treatment of those with T1D. The RAC advises on matters of policy pertaining to research philosophy and procedures to help the organization be most effective. All of this work to convene the best minds in the field enhances JDRF's ability to forecast future scientific direction, to judge the potential efficiency and effectiveness of new pathways and to identify gaps where JDRF can focus its funding to make the most impact. It is from this position of strength that JDRF identified opportunities where the Foundation can make significant advances in the near future and launched a five-year strategic plan in 2015 to accelerate progress to cure, prevent and treat T1D and its complications. LINE 4C ($52,763,561) PUBLIC EDUCATION Because of its leading role in type 1 diabetes (T1D) research globally, JDRF is in a unique position to provide public education about diabetes and its complications. JDRF's efforts impact not only the millions of people with the disease and their families and the general public, but also those at risk for developing the disease. Type 1 diabetes strikes both children and adults suddenly, and the adjustment period following a diagnosis can be overwhelming. JDRF educates people about the warning signs of T1D, which can be profoundly helpful in ensuring timely diagnoses and reducing the potential, short-term, catastrophic consequences of T1D. JDRF also provides information and updates about current research directions and progress and about human clinical trials that are seeking participants (including through JDRF's Clinical Trials Connection matching tool: www.jdrf.org/research/clinical-trials). Through all of its U.S. chapters and online, JDRF supports the T1D communitys diverse needs, connecting people with local support, expert resources and the worldwide effort to end this serious disease.
CONFLICT OF INTEREST POLICYFORM 990- PART VI-SECT B, LINE 12C All officers, directors, key employees, board and committee members (both chapters and international boards) are required to sign a conflict of interest policy annually and disclose any conflicts. The Office of the President and CEO manages this process, and JDRF's internal audit department annually audits to ensure compliance. If any conflict does arise, the board members with the conflicts will recuse themselves from the meeting and/or vote.
PUBLIC DOCUMENTSFORM 990, PAGE 6, PART VI, SECTION C, LINE 19 The organization makes its governing documents, conflict of interest policy and financial statements available to the public on its website: www.JDRF.org. The public may access copies of JDRF's W-9, annual reports, 990 tax returns, 501(c)(3) IRS letter, and audited financials, at the following link: www.jdrf.org/about/financials
EXECUTIVE COMPENSATION POLICYPART VI, SECTION B, LINES 15a & 15b JDRFs Board of Directors charges a Talent and Compensation Committee to develop and recommend a compensation philosophy that applies to all employees of JDRF, including recommendations regarding the compensation and benefits of JDRF senior management for approval by the Executive Committee. The Committee works in collaboration with the President and CEO and the Chief People Officer and other senior staff personnel in the JDRF Human Resources Department to ensure that 1) the Foundations talent strategy supports and is aligned with its overall organization strategies; 2) JDRF is in compliance with IRS guidelines for determining reasonableness in pay practices; and 3) overall compensation for JDRFs key executives is competitive and aligned with pay philosophy. To attract and retain top scientific and executive talent to advance its mission, the organization pays competitive and appropriate salaries as determined by analysis of reliable data and input from independent third-party consultants. The review of JDRF executive compensation and benefits under the procedures noted above is completed annually by an independent Compensation Committee, and the basis for their determination are documented contemporaneously in the minutes of the Committees meetings, including most recently on November 10, 2016.
FORM 990 REVIEW PROCESSSECTION B, PART VI, QUESTION 11B JDRF has a rigorous standard approach to reviewing its 990. The Organization's Tax Manager works with its outside tax professionals to prepare the return and all supporting schedules. The draft return is reviewed by a number of individuals, including JDRFs Chief Financial Officer and Director of Accounting and Finance, the Chief Executive Officer, other executives, its external senior tax advisor and others as necessary to ensure accuracy. Any questions and changes with respect to the draft return are addressed. Following this process, the return is reviewed by JDRFs Audit Committee of the Board of Directors with its outside tax advisors. Once approved, the return is distributed to all members of JDRFs Board of Directors for review and comment before it is filed with the Internal Revenue Service. KEY EMPLOYEE FORM 990, PART VII Jonathan R. Behr, Managing Director of the T1D Fund is a key employee of JDRF. The compensation reported on Part VII represents one month of calendar year 2016.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1JDRF T1D FUND LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1C/O JDRF - 26 BROADWAY 14TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd
FieldValueIRS element (for citing)
EIN274967989EIN
Primary ActivitiesFUNDR/INVESTPrimaryActivitiesTxt
Legal Domicile StateDELegalDomicileStateCd
Total Income$12,612,251TotalIncomeAmt
End Of Year Assets$23,641,793EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1JDRFBusinessNameLine1Txt

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1CHARITABLE REMAINDER TRUST (5)BusinessNameLine1Txt
FieldValueIRS element (for citing)
Primary ActivitiesANNUITYPrimaryActivitiesTxt
Legal Domicile StatePALegalDomicileStateCd
Controlled OrganizationYes (true)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgfalseGiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgfalseRentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesfalseSharingOfFacilitiesInd
Paid Employees SharingfalsePaidEmployeesSharingInd
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgfalseReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE R, PART I, LINE (1B)FormAndLineReferenceDesc
ExplanationTHE PRIMARY ACTIVITY FOR THE JDRF T1D FUND IS FUNDRAISING AND INVESTING IN TYPE ONE DIABETES RESEARCH. PLEASE SEE DETAILED DESCRIPTION ON SCHEDULE O, PART III, LINE 4A, STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS FOR RESEARCH GRANTS.ExplanationTxt

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.